1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with cyclic gmp in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bátkai, S; Begg, M; Kunos, G; Lovinger, DM; Mo, FM; Offertaler, L; Pacher, P; Razdan, RK | 1 |
Krylatov, AV; Lasukova, OV; Maslov, LN; Pertwee, R; Uzhachenko, RV | 1 |
Krylatov, AV; Lishmanov, YB; Maslov, LN | 1 |
3 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and cyclic gmp
Article | Year |
---|---|
G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.
Topics: Animals; Arteries; Calcium; Cannabinoids; Carbazoles; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Dronabinol; Electrophysiology; Endothelium; Endothelium, Vascular; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Guanylate Cyclase; Humans; Indoles; Kinetics; Ligands; Male; Membrane Potentials; Oxadiazoles; Patch-Clamp Techniques; Peptides; Pertussis Toxin; Potassium; Potassium Channels; Quinoxalines; Rats; Rats, Sprague-Dawley; Resorcinols; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Umbilical Veins; Vasodilator Agents | 2003 |
Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: role of cAMP and cGMP.
Topics: Adrenergic beta-Agonists; Animals; Cannabinoid Receptor Agonists; Cyclic AMP; Cyclic GMP; Dronabinol; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Radioimmunoassay; Rats | 2004 |
Role of cyclic nucleotides and NO synthase in mechanisms of cardioprotective effects of cannabinoid HU-210.
Topics: Animals; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dronabinol; Nitric Oxide Synthase; Rats; Rats, Wistar | 2014 |